Compare
SeaStar Medical Holding Corp vs PetVivo Holdings, Inc. vs RenovoRx, Inc. vs Sintx Technologies, Inc.
| Latest fiscal year | SeaStar Medical Holding Corp ICU | PetVivo Holdings, Inc. PETV | RenovoRx, Inc. RNXT | Sintx Technologies, Inc. SINT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.23M | $1.14M | $1.12M | $1.02M |
| Revenue growth (YoY) | +814.1% | +0.8% | n/m | -64.7% |
| Gross margin | 95.7% | 66.1% | 70.9% | 45.3% |
| Operating margin | -986.6% | -793.9% | n/m | n/m |
| Net margin | -984.6% | -917.4% | -994.5% | n/m |
| Net income | -$12.15M | -$10.47M | -$11.17M | -$10.36M |
| EPS (Diluted) | n/a | -$0.38 | -$0.32 | -$6.16 |
| Operating cash flow | -$13.60M | -$6.11M | -$10.97M | -$8.57M |
| Free cash flow | n/a | -$6.12M | -$10.97M | -$8.76M |
| Cash & equivalents | n/a | n/a | $7.02M | $4.14M |
| Total assets | $14.16M | $3.58M | $8.10M | $9.51M |
| Total liabilities | $3.74M | $1.38M | $2.67M | $6.58M |
| Shareholders' equity | $10.42M | $2.20M | $5.42M | $2.93M |
| Return on year-end equity | -116.6% | -476.2% | -206.0% | -353.8% |
| Shares outstanding | 3.84M | 35.85M | 36.61M | 3.97M |
Revenue, most recent five fiscal years
| Fiscal year | SeaStar Medical Holding Corp | PetVivo Holdings, Inc. | RenovoRx, Inc. | Sintx Technologies, Inc. |
|---|---|---|---|---|
| Latest | $1.23M Ended 2025-12-31 | $1.14M Ended 2026-03-31 | $1.12M Ended 2025-12-31 | $1.02M Ended 2025-12-31 |
| 1 year earlier | $135.0K Ended 2024-12-31 | $1.13M Ended 2025-03-31 | $43.0K Ended 2024-12-31 | $2.89M Ended 2024-12-31 |
| 2 years earlier | $0 Ended 2023-12-31 | $968.7K Ended 2024-03-31 | n/a | $2.63M Ended 2023-12-31 |
| 3 years earlier | n/a | $917.2K Ended 2023-03-31 | n/a | $1.56M Ended 2022-12-31 |
| 4 years earlier | n/a | $115.6K Ended 2022-03-31 | n/a | $606.0K Ended 2021-12-31 |